Objectives . The saccharide ultrasound contrast agent SHU 500
The use of color Doppler flow imaging has facilitated the noninvasive diagnosis of valvular disease . However, in adults, the actual display of intracardiac flow is limited because distant structures like the left atrium are subject to increased absorption and scattering of ultrasound . In particular, the classification and quantitation of atrioventricular valve regurgitation may be limited by reduced sensitivity in Doppler interrogation at the depths encountered when the examination is performed from the apical window (1-3) . Enhancement of low intensity Doppler signals by contrast agents has been demonstrated in experimental and human studies (4) (5) (6) (7) (8) , thus revealing information on Doppler studies not otherwise available because of poor signal to noise ratio . ECHOCARDIOGRAPHY the diastolic frame with the maximal color coding from anterograde pulmonary venous flow (red) for planimetry and for grading the intensity of the color Deppler signal (0 to 5) .
Results. The score of the color Doppler signal intensity increased by at2 .5 after 3 g of SHU 508 A (p < 0 .001). Flow detection improved, as shown by the Increased jet area of mitral regurgitation (?170% after 3 g of SHIM 508 A (3 t 3 vs . 12 ± 8 cm5 , p < 0 .001) and by a ia20O% increase in normal anterograde flow area (p < 0 .001) in both the mitral regurgitation group and the control group . After contrast enhancement, the correlation between anglographic grading and the relation of jet area to the left atrial area Increased from r = 0.79 to r = 0 .91 .
Conclusion . Contrast-mediated Increased echogenicity of the left atria] blood pool improves the signal to noise ratio of Doppler Images of ,.nitral regurgitation and anterograde atrial flow. The technique is safe and simple and seems to minimize variability due to instrument design and natomic signal attenuation . 0 Am Coll Cardiol 1993x2: This augmentation has been limited to the tight heart (9) . Recently, a contrast agent capable of pulmonary transmission, SIlO 5 A, has been developed (Schering AG) (10, 11) . In this study, we test the hypothesis that the intravenous saccharide echo contrast agent, SHU 508 A, can enhance color Doppler flow images of regurgitant and forward flow within the left atrium . The major focus of our efforts was to test the ability of this agent to enhance left-sided flow signals in a clinically useful manner, namely, in the improved evaluation of mitral regurgitation .
Methods
Study patients . The protocol for this prospective study was submitted to and approved by the Institutional Review Board of the Technical University, Munich, in December 1989 (established according to Food and Drug A,dminilstration guidelines) . Informed consent was obtained from ail 34 subjects . Patients were unselected with regard to the quality of echocardiographic and color Doppler flow images ; however, one patient had to be excluded because of complete failure of imaging. Ten patients (mean age 55 years [range 23 to 681, mean weight 81 ± 17 kg and mean height 174 9 cm) with sinus rhythm, no murmurs and normal echocardiograms had left heart catheterization for the evaluation of chest pain . Trivial mitral regurgitation by echocardiography and Doppler study was not an exclusion criterion, nor was obesity (n = 4) or emphysema (n = 1) .
Mitral regurgitation group. Twenty-three consecutive patients had left ventricular angiograms for suspected mitral regurgitation . The group consisted of I I men and 12 women (mean age 61 years [range 49 to 78), mean weight 73 ± 13 kg, mean height 169 ± 10 cm) . Obesity was present in three patients and emphysema in two . The causes for valvular disorder were rheumatic valvular disease (n = 6), flail mitral valve leaflet (n = 2), bacterial endocarditis (n = 2), mitral valve prolapse (n = 3), ischemic heart disease (n = 4) . cardiomyopathy (n 4) and hypertensive heart disease (n 2). Six patients had moderate or severe mitral stenosis, and one patient had a bioprosthetic mitral valve. Sinus rhythm was present in I I patients and atrial fibrillation in 12 .
Cardiac catheterization . There was no premedication given before the procedure . Catheters were inserted through the percutaneous femoral route . Biplane left ventricular angiograms were performed in a 30° right anterior oblique and a 60° left anterior oblique projection, with injection of 45 to 55 ml of iopamidol at 12 to 15 mils . The severity of mitral regurgitation was graded as 0 = none . I = mild, 2 = moderate and 3 = severe regurgitation, according to the classification of Nagle et al . (12) . Interpretation was performed by consensus of two observers who were unaware of the clinical and color Doppler data of the patient .
Contrast agent . The contrast agent SHU 508 A is a suspension of galactose microparticles (median diameter 2 on.) in water (300 mglmi). The suspension was prepared 2 min before injection by adding sterile water (13 .5 mi) to the vial with SHU 508 A granules. Using a 20-gauge cannula, 10-ml aliquots of SHU 508 A were hand-injected into an antecubital vein over a period of 2 s, followed by a saline solution flush of 5 ml . A second injection of 3 g followed after 5 min or after contrast effects had completely disappeared . Hemodynamic effects were monitored by pulse rate and blood pressure before and during injection as well as 0.5 and 24 h later. Blood samples were analyzed for electrolytes, urea, liver enzymes, coagulation and hematology before and 0.5 and 24 h after injection . After each injection, patients were questioned about the presence of side effects or any subjl.ctive complaint .
Study design . The study was designed as a two-center study to allow the comparison of both center' data, with blinded evaluation of the color Doppler recordings within each center and subsequent exchange of randomly selected tapes from a subgroup of 14 patients . Blinded reading for interobserver variability included selecting the frame with maximal color-coded areas in the left atrium and quantitating these areas by planimetry . The intercenter interobserver variability was measured by experienced colleagues, who independently evaluated the tapes and were unaware of patient data from the history and clinical examinations . Data v.ere collected using one of three ultrasound devices in random sequence (Hewlett-Packard Sonos 1000 and Toshiba SSH 65A and 160) (represented later in Table 3 by the letters X, Y and Z). Blood presk are and heart rate were measured during both the echocardiographic and angiographic studies .
Doppler examination. Ultrasound investigations were carried out 53 days before angiography while patients were in clinically stable condition . Medications were uninterrupted . Color Doppler examination was performed from the apical views with the patient positioned in left recumbency . Each examination was performed with the use of a 2 .5-MHz transducer, 400-Hz filter setting, 4-kHz pulse repetition frequency, individually optimized gain setting and the narrowest sector angle K60° capable of encompassing the entire left atrium . Machine settings were kept constant for before and during contrast recordings . All studies were stored on VHS videotape for off-line analysis on a Dextra 200 computer system .
Measurements . Pulmonary transmission time of microbubbles was measured as the time observed from the first appearance of color Doppler enhancement in the right atrium to the appearance of color Doppler enhancement in the left atrium to differentiate it from intracardiac shunts . In ,the four-and two-chamber views, we selected the frames with maximal jet area of mitral regurgitation and the diastolic frames with maximal color coding from anterograde pulmonary venous filling in the left atrium . The color-coded areas were measured by planimetry . Mitral regurgitation jet area was defined as those regions of disturbed flow in which there were variance and aliasing . a s well as the immediately contiguous nondisturbed velocities coded in blue . Regurgitation areas were also classified as early systolic (<0 .50 systole) or holosystolic . Measurements were taken from three cardiac cycles and averaged . Cavity area was measured from the same frame as maximal flow . Areas of undi&turbed flow and jet areas were presented as absolute areas cm and were also expressed as a percent of the cavity area. Color Doppler signal intensity of anterograde flow in the left atrium was graded from 0 to 5 0 = no flow detected, I = scarce signals . 2 = weak signals, 3 = moderate signals, 4 = good signals, 5 = signals too strong or artifactual , as previously described 4,13 .
Statistical analysis. Differences between data obtained in individual groups in this study were assessed using nonparametric tests . These were the Wilcoxon signed rank test and Friedman test for paired data and the Mann-Whitney and Kruskal-Wallis tests for unpaired data . The differences were considered significant if p < 0.05 for two-tailed testing . Results are presented as mean value ± SD in the text and tables and as box plots of percertiles in the graphs . Interobserver variability was determined by simple linear regression analysis . 
Results
Enhancement of flow display in the control group . There was ne holosystolic mitral regurgitation in this group . Early systolic regurgitation was visible before administration of SP!J 508 A in one patient and after SHU 508 A in six pe .. ;tents. Thus, jet area increased from 0 .1 ± 0.4 to 1 .4 ± 1 .3 cm 2 p < 0.05 Table 1 . Only 21 ± 24% of the left atrial cross-sectional areas had diastolic color flow signals Fig . 1 before contrast injection . Color Doppler signal enhancement in the right heart chambers was seen ~4 s after intravenous injection . After a pulmonary transit time of 5 ± 2 s, there was a pronounced increase in color Doppler signal intensity in the left atrium Fig . 2 and. 3 . Diastolic color flow area increased by 330% p < 0.001 . In this group, flow enhancement was sufficient to allow delineation of atrial flow in all ; there were no distorting artifacts . Doppler signal enhancement persisted for 63 ± 37 s in the left heart chambers and then gradually subsided without significant differences among patient groups . Enhanced flow display in the mitral regurgitation group. Pulmonary transmission time was 8 ± 3 s_ Using unenhanced Doppler imaging, mitral regurgitation was not visualized in I patient and was displayed in early systole in I I patients and throughout systole in 11 . After contrast injection, the display of regrtrgitation was changed from early to holosystolic in 6 of I I patients when 5 were now classified as having early systolic and 17 as holosystolic regurgitation . After contrast injection, jet area of mitral regurgitation Fig . 4 increased by 270% in the four-chamber view and by 170% in the twochamber view p < 0 .001 Table 1 . Respectively, the relation of jet area to atrial area increased from 15 ± 12% to 46 ± 25% in the four-chatn •.:r view and from 15 ± 13% to 36 ± 22% in the two-chamber view p < 0 .001 . SHU 508 A increased left atrial anterograde flow areas during diastole by 200% p < 0.001 i :; . 1 . In the two patients with a flail mitral valve, the relation of eccentric jet area to left atrial area increased from X19% to -81% after SHU 508 A . The severity of mitral regurgitation as derived from angiography and color Doppler flow areas of anterograde and regr •gitant atrial flow were not significantly different between patients with atrial fibrillation and patients in sinus rhythm . Values in the subset of seven patients with mitral stenosis and a bioprosthetic mitral valve were compa -^d with the mean values of the remaining patients n = iu , with matched degrees of regurgitation before and after SHU 508 A : Anterograde aad retrograde atrial flow areas did not differ significantly between these groups .
Evaluating severity of mitrall regurgitation . By angiographic grading of mitral regurgitation in the mitral regurgitation group, two patients were classified as free of significant regurgitation grade 0 and eight as having grade I , seven as having grade 2 and six as having severe regurgitation . All patients in the control group had grade 0 regurgitation . The distribution of individual jet areas as a percent of left atrial area was compared with the reference grading for all patients, as shown in Figure 5 . Before administration of SHU 508 A, there was poorer discrimination of severity . The correlation coefficient was r = 0 .79 . After contrast enhancement, the individual values agreed closely when compared with the corresponding reference grade r = 0 .91 . Visual inspection revealed an optimal separation of holosystolic jet areas at 10% for no versus mild mitral regurgitation p < 0 .02 , 40% for mild versus moderate p < 0.01 and 70% for moderate versus severe p < 0 .002 .
Study design. Blood pressure 132/82 ± 18110 mm Hg and heart rate 78 ± 11 beats/min during echo contrastt studies were not significantly different from those during cardiac catheterization 133173 ± 16/13 mm Hg, 80 10 beats/min . There were no differences in the size and signal intensity of the color-coded areas when those after the first contrast injection were compared with those after the second injection . There were no significant differences between the two centers in measurements of color Doppler areas before and after contrast injection . When comparing the interobserver variability between two centers and be- tween observers in one center, regression coefficients and standard errors of the mean did not differ significantly for measurements of cavity area and color-coded area before or after SHU 508 A Table 2 . When the three ultrasound devices used in this study were compared, one device demonstrated superior sensitivity for flow detection of normal atrial anterograde flow velocities before and after contrast injection Table 3 . However, the increase in color Doppler flow areas after SHU 508 A was not different among the ultrasound systems . Blood pressure, heart rate and blood chemistry values did not change in the course of the study apart from postural modifications Table 4 . The injections of SHU 508 A were well tolerated by all patients. Three patients mentioned a brief feeling of warmth at the injection site, but there were no adverse effects or sensation a .
Discussion
Doppler signal enhancement by contrast agents . In unenhanced color-coded Doppler flow imaging, the display of intracardiac flow is fragmentary, as shown by the high incidence of anatomically delineated areas without any flow signal . The circulating blood reflects only a small amount of the ultrasound energy for Doppler signal processing . A further reduction of the signal to noise ratio may be due to low velocity of flow, high attenuation or increased interrogation depth 13-15 , so that these signals cannot pass the threshold between noise and display of flow signals in the ultrasound device . Because the low intensity of Doppler signals is caused by the low echogenicity of blood, it may, as First echocardiographic experiences with intravenous injection of the saccharide suspension SHU 508 A in dogs 10 and in healthy volunteers 11 showed it to cause homogeneous opacification of the left side of the heart, with the intensity depending on the dose administered . This report is the first to quantitate its ability to enhance color Doppler flow imaging of the left atrium in patients .
Color Doppler enhancement of anterograde flow . Significant increases in left heart . color Doppler signal intensity were shown both in control subjects and in patients given SHU 508 A Fig . 3 . This enhancement led to increased flow detection, as measured by color-coded areas and also by the duration of mitral regurgitant jets . Because the cardiac cavities are full of flowing blood in the living state, flow detection more closely mirrors reality after contrast enhancement, when -70% of the atrium becomes color-coded from normal anterograde flow Fig . 1 . Improvement of flow display was demonstrated for low flow velocities diastolic atrial flow and high flow velocities regurgitant mitral jet Table 1 . We anticipated increased absorption and attenuation of ultrasound by rheumatically thickened mitral valve structures or bioprostheses . These conditions . however, did not reduce color Doppler enhancement of left atrial flow . Furthermore, attenuation from greater ultrasound interrogation depth appeared to be compensated for by Doppler signal enhancement due to the contrast agent . These in vivo results confirm our in vitro experimental studies using a similar agent that did not traverse the pulmonary bed K . Evaluation of mural regurgitation . There is an increased sensitivity for detection of rcgurgitant jets after contrast enhancement, as shown by the data of the control group . These regurgitant jets have small area dimensions and short duration . They represented trivial or physiologic regurgitation with a low incidence before contrast injection in the control group, probably due to attenuation from obesity . It was found more frequently after contrast enhancement but may be differentiated from pathologic mitral regurgitation Fig . 5 . In patients with pathologic mitral regurgitation, the increase in the regurgitant jet area by -a170 0 Table 1 due to increased echogenicity was not unexpected . It is noteworthy that eccentric jets from flail mitral valve 18 could be enhanced similar to the more central ones, so that the coanda effect 19 was no longer an obvious limitation to the evaluation of severity. In addition, the holosystolic duration of pathologic mitral regurgitation was displayed only after contrast injection in 6 of II patients, whereas th°ir late systolic regurgitant flow had been below the detection threshold in unenhanced color Doppler study . The essential point to be determined is whether contrast enhancement is useful for the assessment of severity of mitral regurgitation . Measuring jet area by color Doppler study, as proposed by Helmcke et al . 20 , has been shown in more recent studies not to be a reliable method for the classification of mitred regurgitation because of individual sensitivity problems due to the patient and the imaging p < 0 .05 versus before 5HU ; tp < 0 .01 versus before SHU ; fp < 0 .05 versus 0.5 h after SHU . UP = blood pressure; GGT = gamma-glutamyl transpoplidase ; sALT = serum alanine amino transFerase : sAST = serum aspartate amino trnnsferase ; SHU = 3 g of SHU 508 A . device 1-3,21,22 . These sensitivity problems are fairly independent of the patient s rhythm, the type of ultrasound machine used or the center where the study was performed . We also demonstrate a wide scatter of the individual jet areas in each angiographic class, with much overlap of data between severe and mild regurgitation in the unenhanced color Doppler images Fig . 5 . After injection of SHU 508 A, the individual values showed improved correlation with "e corresponding angiographic data, indicating Fetter differentiation of the severity of mitral regurgitation .
These results emphasize a basic relation between regurgitant volume and jet area, which is influenced by many variables, such as instrumental, patient and hemodynamic factors the unpredictable sensitivity problems due to anatomic attenuation and penetration depth . Once the sensitivity problems have been resolved by contrast enhancement . classification of mitral regurgitation becomes simply a matter of cardiologic evaluation of routine clinical and hemodynamic factors .
Study limitations. This study did not evaluate whether contrast enhancement compensates for the attenuation caused by metallic prosthetic valves . Larger numbers of patients will be needed or thorough evaluation of contrast effects on color Doppler imaging in other clinical situations . For each application, the doses and concentrations of the contrast agent need to be standardized, as do the mode of injection and instrument settings . Improved detection and display of flow require new criteria for the classification of jets, which will be the task for the near future . Experimental studies, minimizing the problems of ultrasound absorption and attenuation, have demonstrated a major dependence of the spatial jet distribution on hemodynamic factors 15,21,22 . However, the patient combines both anatomic attenuation of unknown extent and hemodynamic variables. There are no clinical data yet as to whether the latter influence jet size beyond the range of clinical utility once the sensitivity problems have been resolved . Quantitative ultrasound techniques for the evaluation of mitral regurgitation are needed and have been proposed 23-25 but have not yet been generally accepted . It is likely that their value in the clinical setting is limited by susceptibility to attenuation problems of color Doppler flow imaging .
Clinical implications . This study has shown the importance of increasing the sensitivity of the color Doppler system for flow detection ard improving flow display, thus allowing observation of all ot the Doppler information available for each individual patient . The need for augmented sensitivity for detection of mitral regurgitation has been obvious since transesophageal color Doppler studies revealed a limited display of mitral regurgitation jet area by transthoracic echocardiography 26,27 . The technique of contrast enhancement is a convenient means of compensavo BIBRA ET AL .
CONTRAST ENHANCEMENT OF COLOR DOPPLER FLOW SIGNALS
Lion, specifically when standard color Doppler study fails because of common physical limitations, as often seen in patients tsth obesity and emphysema. Furthermore, the techniitie remains noninvasive and safe and is well tolerated by p_at ents . These features make it a promising technique for the transthoracic assessment of pulmonary venous flow patterns 28,29 . Further investigations focusing on valvular lesions or on the assessment of ventricular function are necessary . This technique may be an important step toward significant improvement of the quantification of color Doppler data in adults .
